Hanel G, Schonle A, Neumann AS, Nixdorf D, et al. Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. Leukemia 2024 Jan 11. doi: 10.1038/s41375-023-02127.
PMID: 38212534